A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO
文献类型:期刊论文
作者 | Feng, Ji-Feng1,2; Wang, Liang1; Jiang, You-Hua1,2; Yang, Xun1,2 |
刊名 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION
![]() |
出版日期 | 2020 |
卷号 | 72 |
关键词 | Esophageal squamous cell carcinoma Fibrinogen Albumin Prealbumin Cancer-specific survival Overall survival Prognosis |
ISSN号 | 0034-8376 |
DOI | 10.24875/RIC.19003184 |
通讯作者 | Feng, Ji-Feng(Fengjf@zjcc.org.cn) |
英文摘要 | Background: Fibrinogen (Fib) to albumin (ALB) fibrinogen-to-albumin ratio as a prognostic index for esophageal cancer has been confirmed. A novel prognostic index was initially proposed with fibrinogen to prealbumin ratio (FPR) in patients with resectable esophageal squamous cell carcinoma (ESCC). Objective: The objective of the study was to study the prognostic role of the novel prognostic index (FPR) in patients with resectable ESCC without any neoadjuvant treatment. Methods: In this retrospective study, a total of 372 resectable ESCC patients without any neoadjuvant treatment were included. The best cutoff values were selected by the receiver operating characteristic curves. Two Cox regression analyses with forward stepwise (one for categorical variables and the other for continuous variables) were used to evaluate the overall survival (OS) and cancer-specific survival (CSS). Results: The best cutoff point was 0.014 for FPR. Patients with lower levels of FPR (<= 0.014) had better CSS (50.7% vs. 18.0%, p < 0.001) and OS (48.0% vs. 17.6%, p < 0.001) than patients with higher levels of FPR (> 0.014). Multivariate Cox analyses (categorical and continuous) demonstrated that FPR was an independent prognostic factor in CSS (categorical: hazard ratio [HR]: 2.014, 95% confidence interval [CI]: 1.504-2.697, p < 0.001; continuous per 0.01: HR: 1.438, 95% CI: 1.154-1.793, p = 0.001) and OS (categorical: HR: 1.964, 95% CI: 1.475-2.617, p < 0.001; continuous per 0.01: HR: 1.429, 95% CI: 1.146-1.781, p = 0.002). Conclusions: Our study indicated that FPR served as an independent prognostic factor in patients with resectable ESCC. |
WOS关键词 | NEOADJUVANT CHEMORADIOTHERAPY ; PLASMA-FIBRINOGEN ; CANCER ; SURGERY ; CHEMOTHERAPY ; METASTASIS ; PREDICTORS ; MORTALITY |
资助项目 | Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission[2018KY290] ; Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission[2019RC129] ; Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission[2019RC128] |
WOS研究方向 | General & Internal Medicine |
语种 | 英语 |
WOS记录号 | WOS:000518828100007 |
出版者 | INST NACIONAL NUTRICION |
资助机构 | Medical Health Science and Technology Project of the Zhejiang Provincial Health Commission |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/103795] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Feng, Ji-Feng |
作者单位 | 1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Canc Res & Basic Med Sci, Canc Hosp,Dept Thorac Oncol Surg, Beijing, Peoples R China 2.Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Feng, Ji-Feng,Wang, Liang,Jiang, You-Hua,et al. A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO[J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION,2020,72. |
APA | Feng, Ji-Feng,Wang, Liang,Jiang, You-Hua,&Yang, Xun.(2020).A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO.REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION,72. |
MLA | Feng, Ji-Feng,et al."A NOVEL PROGNOSTIC INDEX IN PATIENTS WITH RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: FIBRINOGEN/PREALBUMIN RATIO".REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION 72(2020). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。